Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. (Q54591187)

1 June 2018

title

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. (English)

1 reference

1 June 2018

1 reference

1 reference

Lingeng Lu

1

1 reference

1 June 2018

Dionyssios Katsaros

2

1 reference

1 June 2018

Andrew Wiley

3

1 reference

1 June 2018

I A Rigault de la Longrais

4

1 reference

1 June 2018

Manuela Puopolo

5

1 reference

1 June 2018

Peter Schwartz

6

1 reference

1 June 2018

Herbert Yu

7

1 reference

1 June 2018

language of work or name

English

0 references

publication date

21 July 2006

1 reference

1 June 2018

published in

Gynecologic Oncology

1 reference

1 June 2018

volume

103

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

990-995

1 reference

1 June 2018

Placental-specific IGF-II is a major modulator of placental and fetal growth.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Insulin-like growth factors I and II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Promoter-Dependent Tissue-Specific Expressive Nature of Imprinting Gene, Insulin-like Growth Factor II, in Human Tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

The human insulin-like growth factor II gene contains two development-specific promoters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

mRNA decay in prokaryotes and eukaryotes: different approaches to a similar problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: developmental relationships of the four promoters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

The role of the 5' untranslated region of an mRNA in translation regulation during development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Promoter-specific modulation of insulin-like growth factor II genomic imprinting by inhibitors of DNA methylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Concordant loss of imprinting of the human insulin-like growth factor II gene promoters in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Expression of the insulin-like growth factor system and cancer progression in hormone-treated prostate cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

IGF system components as prognostic markers in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Expression of insulin-like growth factor-2 can predict the prognosis of human colorectal cancer patients: correlation with tumor progression, proliferative activity and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Abnormal expression and structural modification of the insulin-like growth-factor-II gene in human colorectal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death--proliferative and anti-apoptotic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.06.006

10.1016/J.YGYNO.2006.06.006

7 January 2021

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018